FOR IMMEDIATE RELEASE
TORONTO, ON – October 30th, 2019 – SCiAN Services is looking to expand its CDM and Biostatistics departments for 2020 onwards with a call to motivated/career-oriented individuals who are interested in Clinical Data Management and Biostatistics positions at their Toronto and Philadelphia offices:
- Experienced professionals with direct CRO/Pharma/Biotech industry experience
- New graduates who want to learn the trade in an ever-changing, challenging environment
“We are an elite, niche CRO in a world of global CROs. We serve both pharmaceutical and bio-technology companies who are developing innovative, breakthrough therapies (immuno-oncology, targeted, cell and gene therapies) to treat cancers and orphan/rare diseases such as pemphigus vulgaris (PV), myasthenia gravis (MG) and x-linked adrenoleukodystrophy (X-ALD). Our focus has always been the client and their need for timely delivery, quality and project commitment. To keep up with the growing demand for our services, we are aggressively looking for colleagues who want to be part of our next growth cycle. It will unquestionably be the most exciting, challenging, and rewarding phase of the company. Join us if you want exposure to new technologies, clinical trial methodologies and procedures and if you are problem-solvers who thrive on challenges. We offer job flexibility and exceptional compensation for exceptional contribution.” – Dr. Miklos Schulz, CEO.
Click the link below for Career Opportunities
About SCiAN
SCiAN Services is a leading Contract Research Organization (CRO) providing customized clinical trial services for clinical-stage start-ups and mid-size biotechnology companies.
For clinical-stage start-ups, we set-up, manage and execute all study activities from trial design, regulatory filing, trial management, DSMB, safety/DSUR updates, pharmacovigilance, data management, biostatistics and medical writing.
For mid-size bio-pharma companies, we offer large-scale biostatistics, statistical programming and data management services with high quality standards, timelines and deliverables maintained throughout the trial.
With 30+ years of experience in IND stage clinical trials and 690 studies completed, SCiAN’s therapeutic area expertise includes immune-oncology, oncology, CNS, infectious diseases, inflammatory / autoimmune diseases and diabetes.
For more information, please contact:
Jasna Szwagiel
Corporate Communication
Email: jszwagiel@scian.com
URL: www.scian.com
| Head Office 2150 Islington Avenue, Suite 200 Toronto, ON, M9P 3V4 Ph: 416 231 8008 |
Philadelphia 3675 Market Street, 6th Floor Philadelphia, PA 19104 Ph: 267-244-8288 |
California 2950 Buskirk Ave, Walnut Creek, CA 94597 Ph: 925-407-2069 |